2.
Cox多因素分析
Cox multivariate analysis
Category | PFS | OS | |||
HR (95%CI) | P | HR (95%CI) | P | ||
Age (yr) | 1.531 (0.680-3.444) | 0.304 | 0.847 (0.287-2.497) | 0.764 | |
Gender | 0.376 (0.103-1.310) | 0.123 | 0.565 (0.186-1.713) | 0.313 | |
Smoking status | 2.806 (0.738-9.665) | 0.130 | 2.350 (0.989-5.871) | 0.097 | |
EGFR mutation | 0.882 (0.134-5.810) | 0.896 | 0.551 (0.059-5.122) | 0.600 | |
ALK rearrangement | 0.941 (0.164-5.388) | 0.946 | 0.889 (0.158-4.984) | 0.893 | |
Driver mutation | 0.933 (0.136-6.404) | 0.943 | 1.470 (0.167-12.92) | 0.728 | |
Brain metastases | 0.208 (0.492-1.045) | 0.052 | 0.673 (0.364-1.548) | 0.250 | |
Bone metastases | 1.593 (0.775-3.274) | 0.205 | 2.540 (0.916-7.042) | 0.073 | |
Cycles of bevacizumab | 0.290 (0.124-0.678) | 0.004 | 1.297 (0.480-3.504) | 0.608 | |
Platinum-based regimens | 0.814 (0.389-1.701) | 0.584 | 0.650 (0.272-1.549) | 0.331 |